Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v9-FR
Language English French
Date Updated 2022-03-15 2022-01-21
Drug Identification Number 02100606 02100606
Brand name MULTI 12 INJECTION MULTI 12 INJECTION
Common or Proper name MULTI 12 INJECTION MULTI 12 INJECTION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients VITAMIN B12 FOLIC ACID BIOTIN VITAMIN E DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID VITAMIN B12 FOLIC ACID BIOTIN VITAMIN E DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID
Strength(s) 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 2 x 5mL vial set 2 x 5mL vial set
ATC code B05XC B05XC
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-04 2021-11-04
Estimated end date 2022-03-11 2022-03-11
Actual end date 2022-03-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Baxter Product code : 6410 Allocation Effective : 75% Baxter Product code : 6410 Allocation Effective : 75%
Health Canada comments